Oncotelic Therapeutics, Inc.

OTCPK:OTLC Stock Report

Market Cap: US$13.0m

Oncotelic Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:OTLC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Aug 24BuyUS$10,000Vuong TrieuIndividual500,000US$0.02

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of OTLC?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20,111,0314.95%
General Public186,629,50245.9%
Individual Insiders199,529,78249.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 54.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.5%
Vuong Trieu
99,416,746US$3.2m0.51%no data
10.3%
Balaji Baktha
41,630,811US$1.3m0%no data
5.77%
Larn Hwang
23,455,990US$750.6k0%no data
4.2%
Chao Hsiao
17,073,604US$546.4k0%no data
4.13%
Autotelic Inc.
16,780,384US$537.0k0%no data
4.05%
Saranjit Saund
16,456,480US$526.6k0%no data
0.82%
Artius Bioconsulting, Llc
3,330,647US$106.6k0%no data
0.28%
Anthony Maida
1,137,314US$36.4k0%no data
0.088%
Amit Shah
358,837US$11.5k0%no data